Heavy menstrual bleeding: is tranexamic acid a safe adjunct to combined hormonal contraception?
article
OA: closed
CC0
⤵ 1 in-corpus citation
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher's page (linked below)
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
AI-generated summary
This paper reviews the safety of tranexamic acid as an adjunct to combined hormonal contraception for managing heavy menstrual bleeding.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (3)
- REDUCTION OF MENSTRUAL BLOOD LOSS BY DANAZOL IN UNEXPLAINED MENORRHAGIA: LACK OF EFFECT OF PLACEBO 1980
- Effective Treatment of Heavy Menstrual Bleeding With Estradiol Valerate and Dienogest 2011
- Non-steroidal anti-inflammatory drugs for heavy menstrual bleeding 2013
Cited by (1)
References (34)
- Effective Treatment of Heavy Menstrual Bleeding With Estradiol Valerate and Dienogest via openalex
- Non-steroidal anti-inflammatory drugs for heavy menstrual bleeding via openalex
- REDUCTION OF MENSTRUAL BLOOD LOSS BY DANAZOL IN UNEXPLAINED MENORRHAGIA: LACK OF EFFECT OF PLACEBO via openalex
- doi:10.2165/00002018-200831040-00001 via openalex
- doi:10.1097/01.aog.0000238343.62063.22 via openalex
- doi:10.3109/00016349009036161 via openalex
- doi:10.1111/j.1471-0528.1982.tb04727.x via openalex
- doi:10.1016/j.ccc.2016.08.004 via openalex
- doi:10.1016/0002-9394(88)90069-4 via openalex
- doi:10.2165/00002018-200831030-00003 via openalex
- doi:10.1016/j.bpobgyn.2007.03.023 via openalex
- doi:10.1111/j.1538-7836.2008.02921.x via openalex
- W6646194672 via openalex
- W6669539104 via openalex
- doi:10.1055/s-0037-1616122 via openalex
- doi:10.1016/j.contraception.2006.12.018 via openalex
- doi:10.1016/0002-9378(94)90466-9 via openalex
- doi:10.1097/00006254-198207000-00014 via openalex
- doi:10.1097/00006982-199001030-00005 via openalex
- doi:10.1097/aog.0b013e3181f20177 via openalex
- doi:10.1111/1471-0528.14623 via openalex
- doi:10.1016/j.ajog.2013.02.013 via openalex
- doi:10.1016/j.contraception.2014.02.002 via openalex
- doi:10.1016/s0140-6736(76)93013-0 via openalex
- doi:10.1097/00001648-200107000-00016 via openalex
- doi:10.1016/s0140-6736(17)30638-4 via openalex
- doi:10.1783/147118910791749425 via openalex
- doi:10.1007/s10157-003-0254-y via openalex
- doi:10.1016/j.fertnstert.2011.07.347 via openalex
- doi:10.1002/ijgo.12047 via openalex
- doi:10.1016/0002-9394(88)90068-2 via openalex
- doi:10.1055/s-0038-1649475 via openalex
- doi:10.1023/b:card.0000033646.21346.e4 via openalex
- doi:10.2217/whe.12.36 via openalex
Cited by (1)
Source provenance
- openalex
- last seen: 2026-05-11T06:21:44.532445+00:00
License: CC0
· commercial use OK